Nortem Biogroup (XPAR:MLBIO) EBITDA Margin % : 13.46% (As of Dec. 2022)

View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Nortem Biogroup's EBITDA for the six months ended in Dec. 2022 was €0.94 Mil. Nortem Biogroup's Revenue for the six months ended in Dec. 2022 was €6.98 Mil. Therefore, Nortem Biogroup's EBITDA margin for the quarter that ended in Dec. 2022 was 13.46%.

Nortem Biogroup EBITDA Margin % Historical Data

The historical data trend for Nortem Biogroup's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup EBITDA Margin % Chart

Nortem Biogroup Annual Data

Trend

Dec21

Dec22

EBITDA Margin %

15.79

13.46

Nortem Biogroup Semi-Annual Data
	Dec21	Dec22
EBITDA Margin %	15.79	13.46

Competitive Comparison of Nortem Biogroup's EBITDA Margin %

For the Packaged Foods subindustry, Nortem Biogroup's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nortem Biogroup's EBITDA Margin % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Nortem Biogroup's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Nortem Biogroup's EBITDA Margin % falls into.

Nortem Biogroup EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Nortem Biogroup's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	0.94	/	6.983
	=	13.46 %

Nortem Biogroup's EBITDA Margin % for the quarter that ended in Dec. 2022 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2022 )	/	Revenue (Q: Dec. 2022 )
	=	0.94	/	6.983
	=	13.46 %

Nortem Biogroup (XPAR:MLBIO) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Nortem Biogroup EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nortem Biogroup (XPAR:MLBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500

Website

https://www.nortembiogroup.com

Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines